Adults with type 2 diabetes who switched from basal insulin therapy to insulin glargine injection experienced similar numbers of hypoglycemia events and decreases in average HbA1c as those who switched to insulin degludec. READ MORE
Real-World Data Shows Similar Rate of Hypoglycemia Events With Insulin Glargine Injection, Insulin Degludec
Adults with type 2 diabetes who switched from basal insulin therapy to insulin glargine injection experienced similar numbers of hypoglycemia events and decreases in average HbA1c as those who switched to insulin degludec.
Approximately 5.6% of new cancer cases worldwide are attributable to the combined effect of diabetes and a high body mass index.
The Blue Cross Blue Shield Association has announced a partnership with a Google-affiliated company to provide personalized type 2 diabetes care to members of its health plans.
Heart failure patients may be less likely to be hospitalized or die prematurely if they don’t also have diabetes – but even if they do have it, they may still minimize their risk by controlling their blood sugar.
Research in Review
A biomarker screening pathway for monogenic diabetes is an effective and easy approach to systematically screening young-onset patients.
Continuous subcutaneous insulin infusion is associated with increased hypoglycemia encounters and health care expenditures.
Researchers compared angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers for protecting type 2 diabetes patients.
Bariatric surgery is more effective than standard medical treatment for the long-term control of type 2 diabetes in obese patients.
According to a recent clinical practice guideline, the management of type 2 diabetes should include shared decision-making, individualized diabetes self-management education, and individualized glycemic management plans.